Literature DB >> 21389990

Fate of novel painkiller mAbs hangs in balance.

Ken Garber.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21389990     DOI： 10.1038/nbt0311-173

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Tanezumab for the treatment of pain from osteoarthritis of the knee.

Authors:  Nancy E Lane; Thomas J Schnitzer; Charles A Birbara; Masoud Mokhtarani; David L Shelton; Mike D Smith; Mark T Brown
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245
  1 in total
  8 in total

1.  A fully caninised anti-NGF monoclonal antibody for pain relief in dogs.

Authors:  David P Gearing; Elena R Virtue; Robert P Gearing; Alexander C Drew
Journal:  BMC Vet Res       Date:  2013-11-09       Impact factor: 2.741

Review 2.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

Review 3.  The evolution of nerve growth factor inhibition in clinical medicine.

Authors:  Barton L Wise; Matthias F Seidel; Nancy E Lane
Journal:  Nat Rev Rheumatol       Date:  2020-11-20       Impact factor: 20.543

4.  Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?

Authors:  Bernard Bannwarth; Marie Kostine
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 5.  Peripheral changes in endometriosis-associated pain.

Authors:  Matteo Morotti; Katy Vincent; Jennifer Brawn; Krina T Zondervan; Christian M Becker
Journal:  Hum Reprod Update       Date:  2014-05-23       Impact factor: 15.610

6.  In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats.

Authors:  D P Gearing; M Huebner; E R Virtue; K Knight; P Hansen; B D X Lascelles; R P Gearing; A C Drew
Journal:  J Vet Intern Med       Date:  2016-06-15       Impact factor: 3.333

7.  Low-frequency high-magnitude mechanical strain of articular chondrocytes activates p38 MAPK and induces phenotypic changes associated with osteoarthritis and pain.

Authors:  Derek H Rosenzweig; Thomas M Quinn; Lisbet Haglund
Journal:  Int J Mol Sci       Date:  2014-08-19       Impact factor: 5.923

8.  Resiniferatoxin for Pain Treatment: An Interventional Approach to Personalized Pain Medicine.

Authors:  Michael J Iadarola; Gian Luigi Gonnella
Journal:  Open Pain J       Date:  2013-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.